← 홈

Antibody

1,830개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 1,830개
AntibodystaleMargaret Gatti-MaysPhase 2

Naxitamab (Naxitamab)

Anatomic Stage IV Breast Cancer AJCC v8; HER2-Negative Breast Carcinoma · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
임상시험 2상태 RECRUITING
AntibodystaleRoswell Park Cancer InstitutePhase 1

Nimotuzumab (Nimotuzumab)

EGFR Gene Mutation; Recurrent Non-Small Cell Lung Carcinoma · Advanced Cancer

#AdvancedCancer#Antibody#Phase1#항체#면역항체+4
임상시험 2상태 ACTIVE
AntibodystaleBristol Myers SquibbPhase 2

nivolumab (Opdivo, Niraparib + Nivolumab)

Pancreatic Adenocarcinoma · Pancreatic Adenocarcinoma

#PancreaticAdenocarcinoma#Antibody#Phase2#항체#면역항체+2
효능 ORR 7.7%임상시험 2상태 ACTIVE
AntibodystaleBristol Myers SquibbPhase 3

nivolumab (Opdivo, Nivolumab/rHuPH20)

Melanoma · Melanoma

#Melanoma#Antibody#Phase3#항체#면역항체+2
효능 ORR 0%임상시험 2상태 DISCONTINUED
AntibodystaleBeiGenePhase 3

Ociperlimab (Ociperlimab)

Advanced Hepatocellular Carcinoma · FRα

#FR#Antibody#Phase3#항체#면역항체+3
효능 ORR 100%임상시험 2상태 DISCONTINUED
AntibodystaleAbbViePhase 3

adalimumab (Humira, Open-label Adalimumab)

Axial Spondyloarthritis · Axial Spondyloarthritis

#AxialSpondyloarthritis#Antibody#Phase3#항체#면역항체+2
효능 ORR 98.85%임상시험 2상태 ACTIVE
AntibodystaleRocheApproved

Oxaliplatin;Capecitabine;Bevacizumab (Oxaliplatin;Capecitabine;Bevacizumab)

Colorectal Cancer; Liver Metastases · Gastric Cancer

#GastricCancer#Antibody#Approved#항체#면역항체+4
임상시험 2상태 ACTIVE
AntibodystaleMerckPhase 3

MK-3475 (Pembrolizumab, Pembrolizumab (MK-3475))

Merkel Cell Carcinoma · Biliary Tract Neoplasms

#BiliaryTractNeoplasms#Antibody#Phase3#항체#면역항체+3
효능 ORR 49.1%임상시험 2상태 RECRUITING
AntibodystaleEli LillyPhase 2

Penpulimab combined with cetuximab (Penpulimab combined with cetuximab)

Head and Neck Neoplasms; Recurrent Disease · Head and Neck Neoplasms

#HeadandNeckNeoplasms#Antibody#Phase2#항체#면역항체+3
임상시험 2상태 RECRUITING
AntibodystaleInnoventPhase 2

disitamab vedotin (Disitamab Vedotin, RC48, RC48 combined with Sintilimab and XELOX)

Gastric Cancer · Gastric Cancer

#GastricCancer#Antibody#Phase2#항체#면역항체+2
임상시험 2상태 ACTIVE
AntibodystaleRochePhase 2

rituximab (Rituxan, Rituxan (rituximab))

Rheumatoid Arthritis · Lupus Erythematosus, Systemic

#LupusErythematosusSystemic#Antibody#Phase2#항체#면역항체+3
임상시험 2상태 ACTIVE
AntibodystaleRocheApproved

Rituximab Infusion (Rituximab Infusion)

Multiple Sclerosis · Nephrotic Syndrome

#NephroticSyndrome#Antibody#Approved#항체#면역항체+3
임상시험 2상태 ACTIVE
AntibodystaleRochePhase 2

Rituximab/Gemcitabine/Oxaliplatin (Rituximab/Gemcitabine/Oxaliplatin)

Refractory Aggressive Non-Hodgkin's Lymphoma; Relapsing Aggressive Non-Hodgkin's Lymphoma · Combination Therapy

#CombinationTherapy#Antibody#Phase2#항체#면역항체+4
효능 ORR 69.7%임상시험 2상태 RECRUITING
AntibodystaleMerck Sharp & Dohme LLCPhase 2

Robatumumab (Robatumumab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 2상태 DISCONTINUED
AntibodystaleNovartis PharmaceuticalsPreclinical

Secikinumab (Secikinumab)

Axial Spondylarthritis (axSpA); Secukinumab · Psoriasis

#Psoriasis#Antibody#Preclinical#항체#면역항체+4
임상시험 2상태 ACTIVE
AntibodystaleMacroGenicsPhase 3

Tebotelimab (Tebotelimab)

Gastric Cancer; Gastroesophageal Junction Cancer · Head and Neck Cancer

#HeadandNeckCancer#Antibody#Phase3#항체#면역항체+4
효능 ORR 62.5%임상시험 2상태 DISCONTINUED
AntibodystaleBeiGenePhase 2

atezolizumab (Tecentriq, Tislelizumab/Atezolizumab/ Durvalumab/Benmelstobart/Toripalimab/Serplulimab)

Extensive Stage Lung Small Cell Cancer · Extensive Stage Lung Small Cell Cancer

#ExtensiveStageLungSmallCellCance#Antibody#Phase2#항체#면역항체+2
임상시험 2상태 RECRUITING
AntibodyBiologicstaleShanghai Kechow Pharma, Inc.Phase 2

Tunlametinib+PD-1 mAb (Tunlametinib+PD-1 mAb)

Gastric Adenocarcinoma · PD-1

#PD-1#Antibody#Phase2#항체#면역항체+3
임상시험 2상태 RECRUITING
AntibodystaleRochePhase 1

trastuzumab (Herceptin, US sourced Herceptin®)

Healthy · Healthy

#Healthy#Antibody#Phase1#항체#면역항체+2
임상시험 2상태 ACTIVE
AntibodystaleXencor, Inc.Phase 2

XmAb18087 (XmAb18087)

Merkel Cell Carcinoma; Small Cell Lung Cancer · Merkel Cell Carcinoma

#MerkelCellCarcinoma#Antibody#Phase2#항체#면역항체+3
임상시험 2상태 DISCONTINUED

20 / 92 페이지

← 이전다음 →